BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28182304)

  • 1. Benign prostatic hyperplasia after prostatic arterial embolization in a canine model: A 3T multiparametric MRI and whole-mount step-section pathology correlated longitudinal study.
    Li B; Xu A; Wang N; Min X; Feng Z; Deng M; Li L; Cai J; Kang Z; Jiang K; Kuang D; Wang L
    J Magn Reson Imaging; 2017 Oct; 46(4):1220-1229. PubMed ID: 28182304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI features after prostatic artery embolization for the treatment of medium- and large-volume benign hyperplasia.
    Zhang H; Shen Y; Pan J; Wang H; Zhong Y; Wang Y; Ye H
    Radiol Med; 2018 Oct; 123(10):727-734. PubMed ID: 29752646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of contrast-enhanced ultrasonography in detection of prostatic infarction after prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia.
    Moschouris H; Stamatiou K; Malagari K; Marmaridou K; Kladis-Kalentzis K; Kiltenis M; Papadogeorgopoulos N; Tsavari A; Manoloudaki K
    Diagn Interv Radiol; 2019 Mar; 25(2):134-143. PubMed ID: 30860077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic Artery Embolization for Benign Prostatic Hyperplasia: Bleomycin-Eluting versus Bland Microspheres in a Canine Model.
    Zhang JL; Yuan B; Wang MQ; Fu JX; Duan F; Wang T; Shen L; Wang Y; Liu JH; Shen YG; Wang XQ; Zhang HT; Li HW; Yan JY; Song ZG
    J Vasc Interv Radiol; 2020 May; 31(5):820-830. PubMed ID: 32305243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The STREAM Trial (Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia) 24-Month Clinical and Radiological Outcomes.
    Tapping CR; Little MW; Macdonald A; Mackinnon T; Kearns D; Macpherson R; Crew J; Boardman P
    Cardiovasc Intervent Radiol; 2021 Mar; 44(3):436-442. PubMed ID: 33210152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-vesical Prostatic Protrusion (IPP) Can Be Reduced by Prostatic Artery Embolization.
    Lin YT; Amouyal G; Thiounn N; Pellerin O; Pereira H; Del Giudice C; Déan C; Sapoval M
    Cardiovasc Intervent Radiol; 2016 May; 39(5):690-695. PubMed ID: 26542027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can prostatic arterial embolisation (PAE) reduce the volume of the peripheral zone? MRI evaluation of zonal anatomy and infarction after PAE.
    Lin YT; Amouyal G; Correas JM; Pereira H; Pellerin O; Del Giudice C; Déan C; Thiounn N; Sapoval M
    Eur Radiol; 2016 Oct; 26(10):3466-73. PubMed ID: 26738505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenomatous-Dominant Benign Prostatic Hyperplasia (AdBPH) as a Predictor for Clinical Success Following Prostate Artery Embolization: An Age-Matched Case-Control Study.
    Little MW; Boardman P; Macdonald AC; Taylor N; Macpherson R; Crew J; Tapping CR
    Cardiovasc Intervent Radiol; 2017 May; 40(5):682-689. PubMed ID: 28194505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
    Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
    AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Magnetic resonance imaging of the prostate: usefulness of diffusion sequences in detecting postembolization ischemia in patients with benign prostatic hyperplasia].
    Serrano E; Ocantos J; Kohan A; Kisilevsky N; Napoli N; García-Mónaco R
    Radiologia; 2016; 58(2):129-35. PubMed ID: 26494491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Prostatic Artery Embolization on the Dynamic Component of Benign Prostate Hyperplasia as Assessed by Ultrasound Elastography: A Pilot Series.
    de Assis AM; Moreira AM; Carnevale FC; Marcelino ASZ; de Oliveira Cerri LM; Antunes AA; Srougi M; Cerri GG
    Cardiovasc Intervent Radiol; 2019 Jul; 42(7):1001-1007. PubMed ID: 30993369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Clinical Outcome after Prostate Artery Embolization with Spherical and Nonspherical Polyvinyl Alcohol Particles in Patients with Benign Prostatic Hyperplasia.
    Bilhim T; Pisco J; Pereira JA; Costa NV; Fernandes L; Campos Pinheiro L; Duarte M; Oliveira AG
    Radiology; 2016 Oct; 281(1):289-300. PubMed ID: 27223621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embolization therapy for benign prostatic hyperplasia: influence of embolization particle size on gland perfusion.
    Brook OR; Faintuch S; Brook A; Goldberg SN; Rofsky NM; Lenkinski RE
    J Magn Reson Imaging; 2013 Aug; 38(2):380-7. PubMed ID: 23239260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer.
    Chatterjee A; Gallan AJ; He D; Fan X; Mustafi D; Yousuf A; Antic T; Karczmar GS; Oto A
    Abdom Radiol (NY); 2019 Jun; 44(6):2233-2243. PubMed ID: 30955071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study.
    Antunes AA; Carnevale FC; da Motta Leal Filho JM; Yoshinaga EM; Cerri LM; Baroni RH; Marcelino AS; Cerri GG; Srougi M
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):978-86. PubMed ID: 23580116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI assessment of prostatic ischaemia: best predictor of clinical success after prostatic artery embolisation for benign prostatic hyperplasia.
    Kisilevzky N; Faintuch S
    Clin Radiol; 2016 Sep; 71(9):876-82. PubMed ID: 27296474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast enhanced ultrasound (CEUS) with parametric imaging and time intensity curve analysis (TIC) for evaluation of the success of prostate arterial embolization (PAE) in cases of prostate hyperplasia.
    Jung EM; Wertheimer T; Putz FJ; Jung F; Kammerer S; Pregler B; Luerken L; Stroszczynski C; Beyer L
    Clin Hemorheol Microcirc; 2020; 76(2):143-153. PubMed ID: 32925006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging findings of the prostate gland following prostate artery embolization: results from a prospective phase 2 study.
    Ali R; Gabr A; Mouli SK; Kallini JR; Riaz A; Mora R; Lewandowski RJ; Hohlastos E; Casalino DD; Hofer MD; Hamoui N; Miller FH; Hairston J; Salem R
    Abdom Radiol (NY); 2019 Feb; 44(2):713-722. PubMed ID: 30196364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic Artery Embolization (PAE) for Benign Prostatic Hyperplasia (BPH) with Haematuria in the Absence of an Upper Urinary Tract Pathology.
    Tapping CR; Macdonald A; Hadi M; Mortensen C; Crew J; Protheroe A; Little MW; Boardman P
    Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1160-1164. PubMed ID: 29582127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.